Skip to main content

This job has expired

Sr. Statistical Programmer

Employer
Seagen
Location
Bothell, Washington State
Salary
DOE
Closing date
Jun 30, 2019

Job Details

Summary: 

Designs, develops, evaluates and modifies SAS programs to analyze and evaluate clinical data. Recognizes inconsistencies and initiates resolution of data problems. Implements statistical analysis plans designed to meet project and protocol deadlines; provides expertise in the design and development of clinical trials, protocols and case report forms. Acts as a liaison between clinical management, subcommittees and project teams as needed. Interacts with study teams at a high level to proactively determine programming tasks, timelines, assignments, and resource requirements. Oversees study programming effort to ensure the timely delivery of high quality outputs that are produced according to company and industry standards. Assists programming management with process improvement initiatives and resource allocation. 

 

Responsibilities: 

  • Develop and validate SAS® programs to produce high quality deliverables within set timelines in accordance with company and regulatory requirements. The deliverables include datasets, tables, listings and figures
  • Review and provide feedback on deliverables from other clinical groups including but not limited to: statistical analysis plans; table, listing, and figure shells; data management plans; data transfer plans; Safety Report Specification; electronic data entry screens; and case report forms
  • Clear and proactive communication with Study / Project teams to clarify requirements and specifications, update others on assignment status, and to convey data irregularities
  • Oversee study programming effort to ensure the timely delivery of high quality outputs that are produced according to company and industry standards
  • Provide support on initiatives that facilitate infrastructure & process enhancements within Biometrics
  • Train and mentor junior programmers

 

Qualifications:

  • BS or equivalent relevant education and 7+ years or MS/PhD and 5+ years of software development and/or programming experience in the Biotech, Pharmaceutical, Medical Device, and Health Care industries; years of experience may substitute for education
  • Advanced SAS® skills
  • 3+ years of experience in performing statistical programming using SAS® for creating & testing Analysis Datasets, Tables, Listings and Figures for Phase I-IV clinical studies
  • 2+ years of experience in writing SAS® Macros

 

Preferred:

  • Experience with oncology clinical studies
  • Experience implementing CDISC standards
  • Experience with regulatory submissions (e.g. BLA, NDA, NDS, MAA, etc.)
  • Experience with additional programming languages and tools such as S-Plus, R, SPSS, Perl, VBA, MS Access, MS Excel, and SQL that interface with SAS
  • Positive attitude and an ability to creatively use programming skills across variety of tasks in the Clinical Programming area
  • Good written and verbal communication skills

As the leading employer in our industry in the Pacific Northwest, Seattle Genetics is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. Benefits include medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Seattle Genetics, please visit www.seattlegenetics.com.

Seattle Genetics is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law.

Company

Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We’re driven by a singular mission—to make a difference for people impacted by cancer.

As an industry leader in antibody–drug conjugate (ADC) technology, we pioneered the science of harnessing antibodies designed to deliver cell-killing agents to cancer cells. Three of our four approved medicines are built on this technology.

We also focus our research efforts on novel targeted small molecule therapies. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents.

Company info
Website

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert